Apollo Hospitals Enterprise Limited vs Samrat Pharmachem Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Samrat Pharmachem Ltd (SAMRATPHARMACHEMLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs SAMRATPHARMACHEMLTD on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability40
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

SAMRATPHARMACHEMLTD takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
0.00
13.46
P/B ratio
1.05
0.22%
Dividend yield
0.43%
₹135.04
EPS
₹23.01

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
-5.19%
17.31%
Return on capital
13.00%
14.94%
EBITDA margin
3.60%
7.94%
Net margin
2.45%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-2.24%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹71 Cr
₹25,229 Cr
Revenue
₹286 Cr
₹2,003 Cr
Net profit
₹7 Cr
0.90
Debt / equity
0.16
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Samrat Pharmachem Ltd
  • + ["Stock is trading at 1.03 times its book value"]
  • − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 10.1% over past five years.", "Company has a low return on equity of 2.15% over last 3 years."]
Apollo Hospitals Enterprise Limited full analysis Samrat Pharmachem Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs SAMRATPHARMACHEMLTD: Share Price, Valuation & Which to Buy | DocStoX